While Revolution Medicines Inc has underperformed by -2.42%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RVMD fell by -14.31%, with highs and lows ranging from $62.40 to $29.17, whereas the simple moving average fell by -13.58% in the last 200 days.
On July 16, 2024, Needham Reiterated Revolution Medicines Inc (NASDAQ: RVMD) to Buy. A report published by Barclays on July 12, 2024, Initiated its previous ‘Overweight’ rating for RVMD. Jefferies also rated RVMD shares as ‘Buy’, setting a target price of $63 on the company’s shares in an initiating report dated July 08, 2024. Needham Reiterated the rating as Buy on April 12, 2024, but set its price target from $36 to $46. Raymond James April 10, 2024d its ‘Outperform’ rating to ‘Strong Buy’ for RVMD, as published in its report on April 10, 2024. Piper Sandler’s report from March 11, 2024 suggests a price prediction of $43 for RVMD shares, giving the stock a ‘Overweight’ rating. BofA Securities also rated the stock as ‘Buy’.
Analysis of Revolution Medicines Inc (RVMD)
One of the most important indicators of Revolution Medicines Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -36.68% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.46, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and RVMD is recording 1.98M average volume. On a monthly basis, the volatility of the stock is set at 4.27%, whereas on a weekly basis, it is put at 5.36%, with a loss of -6.14% over the past seven days. Furthermore, long-term investors anticipate a median target price of $72.91, showing growth from the present price of $37.48, which can serve as yet another indication of whether RVMD is worth investing in or should be passed over.
How Do You Analyze Revolution Medicines Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 13.09%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 93.67% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RVMD shares are owned by institutional investors to the tune of 93.67% at present.
